Ultrahypofractionated radiation therapy for breast cancer: two-year normal tissue effects. (November 2022) - Oulkadi, R.; Amrouch, S.; Dabach, A.; Schaerlaeken, K.; Weytjens, R.; Billiet, C.; Poortmans, P.; Machiels, M.